Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 13 Jul 2025
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presented Saturday at ENDO ...
Read Full NewsJean Bourbeau, MD, says AI analysis of CT scans is not ready for routine use but could reshape early COPD diagnosis as GOLD expands its AI guidance.
A TETON-2 post hoc analysis at CHEST 2026 found 126 progression events with inhaled treprostinil vs 161 with placebo across 52 weeks.
Voceryq Gains FDA Accelerated Approval for Recurrent Respiratory Papillomatosis
Shaida Khan, DO, associate professor of neurology at UT Southwestern Medical Center, reflected on a recent NeurologyLive Clinical Forum on generalized myasthenia gravis and discussed how FcRn and complement inhibitors are reshaping treatment algorithms for the disease.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 30, 2026.
Although ocular signs in LEMS are typically mild and appear late, recognizing them alongside proximal weakness and autonomic symptoms can speed diagnosis and earlier detection of an associated lung cancer.
Balcinrenone Plus Dapagliflozin Lowers BP, With Adriana Marton, MD
1.
Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup
2.
A US health panel advises starting mammograms at age 40 rather than 50.
3.
Mouse study finds tirzepatide slowed obesity-associated breast cancer growth
4.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
5.
Smoker's Painless Skin Nodules Flag a Fatal Diagnosis
1.
Robotic Intratumoral Resection for Organ Preservation: Current Evidence and Clinical Implications
2.
Oncology Treatment-Planning Simulation: Integrating Evidence, Technology, and Clinical Practice
3.
Understanding Mantle Cell Lymphoma Prognosis.
4.
Exosomes in Cancer: A Novel Frontier for Therapy and Biomarker Discovery
5.
Uncovering the Mystery of the Sessile Serrated Adenoma
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
2.
Navigating the Complexities of Ph Negative ALL - Part XII
3.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
4.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
5.
Thromboprophylaxis In Medical Settings- An Update
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge